People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before symptoms.
Category: Drugs (Pharmaceuticals)
-
Johnson & Johnson Proposes $6.5 Billion in New Talc Settlement Offer
The offer is the company’s third attempt to resolve tens of thousands of claims that its baby powder caused ovarian cancer and mesothelioma.
-
How Supplement Stores Are Trying to Tap Into the Ozempic Boom
GNC and the Vitamin Shoppe are redesigning displays and taking other steps to appeal to people who are taking or are interested in drugs like Ozempic and Wegovy.
-
U.S. Lags Behind Other Countries in Hepatitis-C Cures
Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval.
-
FDA Approves Antibiotic to Treat Urinary Infections
Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
-
How Ozempic Is Transforming a Small Danish Town
In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.
-
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
-
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
-
Global Stockpile of Cholera Vaccine Is Gone as Outbreaks Spread
One company is going to great lengths to build it up, but it will be years before it returns to the minimum level.
-
A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says
Results of a large clinical trial found the treatment did not work any better than a placebo.
-
The Psychedelic Evangelist
A Johns Hopkins scientist was known for rigorous studies of psychedelics. Was he a true believer?